psychoneuro, Table of Contents psychoneuro 2005; 31(9): 409-410DOI: 10.1055/s-2005-917972 Blickpunkt © Georg Thieme Verlag KG Stuttgart · New York Bipolare Störungen und Epilepsien - Neue Therapieoptionen mit Valproinsäure - Mikroperlen Recommend Article Abstract Full Text References Literatur 1 Bowden CL. Brugger AM. Swann AC. Calabrese JR. Janicak PG. Petty F. et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. JAMA. 1994; 271 (12) 918-924 1 Bowden CL. Calabrese JR. McElroy SL. Gyulai L. Wassef A. Petty F. et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch Gen Psychiatry . 2000; 57 481-489 1 Dulac O. Alvarez JC. Bioequivalence of a new sustained-release formulation of sodium valproate, valproate modified-release granules, compared with existing sustained-release formulations after once- or twice-daily administration. Pharmacotherapy. 2008; 25 (1) 35-41 1 Freeman TW. Clothier JL. Pazzaglia P. Lesem MD. Swann AC. A double-blind comparison of valproate and lithium in the treatment of acute mania. Am J Psychiatry. 1992; 149 (1) 108-111 1 Hirschfeld R. Weisler RH. Keck PE. Cost-effectiveness evaluation of divalproex versus lithium in the treatment of bipolar disorder. 152nd APA Annual meeting abstracts, NR 686. 1999; 1 Motte J. AME-Study. Poster präsentiert auf dem 26th International Epilepsy Congress 28. August - 1. September 2005 in Paris. 1 Müller-Oerlinghausen B. Retzow A. Henn F. Giedke H. Walden J. Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania. A prospective, randomized, double- blind, placebo-controlled multicenter study. J Clin Psychopharmacol. 2000; 20 195-203 1 Pope HG. McElroy SL. Keck PE. Hudson JI. Valproate in the treatment of acute mania. A placebo-controlled study. Arch Gen Psychiatry. 1991; 48 (1) 62-68 1 Tohen M. Ketter TA. Zarate CA. Suppes T. Frye M. Altshuler L. et al. Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. Am J Psychiatry. 2003; 160 (7) 1263-1271 1 Weiss SR. Post RM. Kindling: separate vs. shared mechanisms in affective disorders and epilepsy. Neuropsychobiology. 1998; 38 (3) 167-180 1 Zajecka JM. Weisler R. Sachs G. Swann AC. Wozniak P. Sommerville KW. A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder. J Clin Psychiatry. 2002; 63 (12) 1148-1155